Basit öğe kaydını göster

dc.contributor.authorMatsushita, T
dc.contributor.authorNichols, WC
dc.contributor.authorTerry, VH
dc.contributor.authorWheatley, MA
dc.contributor.authorYang, A
dc.contributor.authorZivelin, A
dc.contributor.authorCiavarella, N
dc.contributor.authorStefanile, C
dc.contributor.authorSaito, H
dc.contributor.authorde Bosch, NB
dc.contributor.authorRuiz-Saez, A
dc.contributor.authorTorres, A
dc.contributor.authorThompson, AR
dc.contributor.authorFeinstein, DI
dc.contributor.authorWhite, GC
dc.contributor.authorNegrier, C
dc.contributor.authorVinciguerra, C
dc.contributor.authorAktan, M
dc.contributor.authorKaufman, RJ
dc.contributor.authorGinsburg, D
dc.contributor.authorSeligsohn, U
dc.date.accessioned2021-03-03T08:54:41Z
dc.date.available2021-03-03T08:54:41Z
dc.date.issued1999
dc.identifier.citationNichols W., Terry V., Wheatley M., Yang A., Zivelin A., Ciavarella N., Stefanile C., Matsushita T., Saito H., de Bosch N., et al., "ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families", BLOOD, cilt.93, sa.7, ss.2261-2266, 1999
dc.identifier.issn0006-4971
dc.identifier.othervv_1032021
dc.identifier.otherav_1a2a5415-d6f8-455f-9ee6-cea6fa6723bb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/22863
dc.description.abstractCombined factors V and VIII deficiency is an autosomal recessive bleeding disorder associated with plasma levels of coagulation factors V and VIII approximately 5% to 30% of normal. The disease gene was recently identified as the endoplasmic reticulum-Golgi intermediate compartment protein ERGIC-53 by positional cloning, with the detection of two founder mutations in 10 Jewish families. To identify mutations in additional families, the structure of the ERGIG-53 gene was determined by genomic polymerase chain reaction (PCR) and sequence analysis of bacterial artificial chromosome clones containing the ERGIC-53 gene. Nineteen additional families were analyzed by direct sequence analysis of the entire coding region and the intron/exon junctions. Seven novel mutations were identified in 10 families, with one additional family found to harbor one of the two previously described mutations. All of the identified mutations would be predicted to result in complete absence of functional ERGIC-53 protein. In 8 of 19 families, no mutation was identified. Genotyping data indicate that at least two of these families are not linked to the ERGIC-53 locus. Taken together, these results suggest that a significant subset of combined factors V and VIII deficiency is due to mutation in one or more additional genes. (C) 1999 by The American Society of Hematology.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.titleERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families
dc.typeMakale
dc.relation.journalBLOOD
dc.contributor.department, ,
dc.identifier.volume93
dc.identifier.issue7
dc.identifier.startpage2261
dc.identifier.endpage2266
dc.contributor.firstauthorID123208


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster